Show 1278: Evaluating the Benefits and Risks of Medical Breakthroughs

The People's Pharmacy

Joe and Terry Graedon

Health & Fitness, Medicine, Kids & Family, Alternative Health

4.5 • 934 Ratings

🗓️ 28 October 2021

⏱️ 60 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Everyone gets excited about the idea of medical breakthroughs. Fewer of us, if we are honest, are anxious to be the first one to benefit. After all, if you are the first, you know nothing about the potential harms, and neither does the person offering you the experience. Medical innovation is necessarily fraught with uncertainty. […]

Transcript

Click on a timestamp to play from that location

0:00.0	I'm Joe Gradyton and I'm Terry Grady welcome to this podcast of the People's Pharmacy.
0:06.1	You can find previous podcasts and more information on a range of health topics at people's pharmacy.
0:12.4	com.
0:14.0	Everyone loves medical breakthroughs,
0:17.0	but the road to medical innovation is also fraught with unavoidable risks.
0:22.0	This is the people's pharmacy with Terry and Joe Grady. This is the People's Pharmacy with Terry and Joe Grady.
0:26.0	We all have a hard time assessing risks. Even though we may know that driving a car is dangerous,
0:40.0	most of us don't think twice before we turn the key in the ignition.
0:43.6	On the other hand, we may worry about the dangers of vaccines.
0:47.6	How do we put all this into perspective?
0:50.3	Dr Paul Offord is a pediatrician and an expert on vaccines. His new book is You Bet Your Life.
1:00.0	Coming up on the People's Pharmacy, the long and risky history of medical innovation. In the people's pharmacy health headlines, research on people who have had COVID-19 demonstrates that symptoms can interfere with quality of life long after the initial infection.
1:27.0	One study included 740 patients who are followed up between April 2020 and May 2021.
1:34.0	In addition to receiving care for their symptoms,
1:37.0	these volunteers took several tests to assess cognitive functioning.
1:41.0	A significant number of them had trouble with
1:44.2	attention, memory, executive function, processing speed, or language. The average age
1:50.9	of participants was 49 and the average time since COVID diagnosis was over seven months.
1:58.0	None had a history of dementia despite the brain fog they were experiencing post-Covid.
2:04.0	Another study included survey results from 156 people participating in a long COVID clinic.
2:12.0	They'd been diagnosed with COVID-19 infection
2:15.0	an average of a year earlier.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Joe and Terry Graedon, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Joe and Terry Graedon and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.